MOSS Institute Co., Ltd. And AnGes MG Inc. Tie Up In Genomic Drug Development
10/19/2005 5:09:34 PM
MOSS Institute and AnGes MG (TSE: 4563) have announced that the two companies have reached a basic agreement on development of a new critical trial system for genomic drug development.
comments powered by